Skip to content

Medical-device intelligence

Biokit USA, Inc.: FDA clearances and recalls

Research Biokit USA, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

16 clearance records and 0 recall records in the covered releases, across 1 source company names and 9 product codes. Dated history runs from Jun 19, 1984 to Jan 11, 1993.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

16 matching records
Device / recordCompany in FDA recordSourceSource date
TOXOGENK913467 · LLABiokit USA, Inc.510(k)Jan 11, 1993FDA decision date
BIOKIT RPRK910541 · GMQBiokit USA, Inc.510(k)Oct 18, 1991FDA decision date
RHEUMAGEN RF T-CONTROLK904310 · DHRBiokit USA, Inc.510(k)May 31, 1991FDA decision date
RHEUMAJET RFK910539 · DHRBiokit USA, Inc.510(k)Apr 5, 1991FDA decision date
RHEUMAJET CRPK910686 · DCNBiokit USA, Inc.510(k)Mar 19, 1991FDA decision date
RHEUMAGEN ASO T-CONTROLK904311 · GTQBiokit USA, Inc.510(k)Jan 25, 1991FDA decision date
RHEUMAGEN CRP T-CONTROLK904312 · DCKBiokit USA, Inc.510(k)Oct 1, 1990FDA decision date
MODIFIED RUBAGENK896433 · LQNBiokit USA, Inc.510(k)Nov 29, 1989FDA decision date
QUANTEX RF PLUS (LATEX, BUFFER STANDARD, CONTROL)K896271 · DHRBiokit USA, Inc.510(k)Nov 8, 1989FDA decision date
QUANTEX CRP PLUS (LATEX, BUFFER, STANDARD, CONTROLK896272 · DCNBiokit USA, Inc.510(k)Nov 8, 1989FDA decision date
QUANTEX ASO PLUS (LATEX,BUFFER STANDARD,CONTROL)K894486 · GTQBiokit USA, Inc.510(k)Oct 24, 1989FDA decision date
RUBAGENK893755 · LQNBiokit USA, Inc.510(k)Aug 21, 1989FDA decision date
I.M.N. LATEXK874678 · KTNBiokit USA, Inc.510(k)Dec 14, 1987FDA decision date
REUMAGEN ASLK854991 · GTQBiokit USA, Inc.510(k)Apr 18, 1986FDA decision date
RPR TEST REDITESTK843741 · GMPBiokit USA, Inc.510(k)Oct 25, 1984FDA decision date
AS LATEX PLUSK842256 · GTQBiokit USA, Inc.510(k)Jun 19, 1984FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗